Roundtable topics
Join industry leaders for the types of intimate discussions that have become rare in the last year. Places are limited so make sure you
book your ticket
today to be first in line to secure a seat at the table.
If you want more information about the sessions, take a look at the detailed agenda.
|
NAD+ Next Breakthrough: New Human Clinical Results Show NMN Improves Memory & Sleep - Exploring Our Clinical Evidence & Regulatory Milestones.
Host: Sherry Li, Sales Manager at EffePharm This roundtable will focus on the latest human clinical evidence from UTHEVER Ⓡ NMN Phase II clinical study, exploring a key question: to what extent can NMN or NMNH improve memory and sleep? And how could these new findings contribute to the development of next-generation healthy ageing and cognitive health products? The discussion will also explore the rapidly evolving global regulatory environment for NMN and other dietary supplements. UTHEVER® NMN has achieved significant breakthroughs in the Novel Food and FDA NDI regulatory processes in 2026. Discover how these regulatory milestones achieved provide a reliable foundation for nutrition brands. |
 | Phytonutrients and Healthy Longevity: What Do We Know, and What Comes Next? Host: Cosimo Palumbo, Chief Operating Officer, & Tim de Lange, Global Director of Applications at Indena Ageing is characterised by a progressive decline in physiological resilience, driven by interconnected molecular and cellular hallmarks that ultimately affect function, appearance, and quality of life. As life expectancy increases, the focus is shifting from simply extending lifespan to preserving healthspan. This roundtable will explore how natural bioactive compounds may support healthy ageing by acting across multiple biological pathways, what the current evidence truly supports, and where the science needs to go next. Drawing on Indena’s phytochemical expertise, we will discuss how rigorous research can translate botanical innovation into credible, sustainable strategies for healthy longevity. |
 | Brain Health and Magnesium: What Does the Evidence Support? Host: Dr. Rafea Naffa, Director R&D Magtein® at Magtein®/ThreoTech Dr. Rafea Naffa, Director of R&D at ThreoTech, hosts an informal discussion on magnesium and the ageing brain. Using Magtein® magnesium L-threonate as a case study, the table will explore what preclinical research shows about magnesium delivery to the brain, what randomised, placebo-controlled human trials show for cognitive performance, healthy brain ageing, and sleep quality. Delegates will leave with practical insight into evaluating cognitive-health ingredients, choosing doses and formats, and communicating benefits within today's claims landscape. Bring your questions. |
 | Bioavailability and the impact at the cellular level - how advanced delivery systems can change this. Host: George Kokkinis, Managing Director Pharmako Biotechnologies at Pharmako Biotechnologies/Saanroo At this roundtable, they will discuss how cellular-level absorption constraints shape nutrient efficacy and why overcoming bioavailability bottlenecks is critical to modern healthspan solutions. Join them to learn about Pharmako Biotechnologies’ award-winning delivery platforms—including LipiSperse® cold-water dispersion, AquaCelle® self-micro-emulsifying technology (SMEDDS), and PlexoZome® liposomes. This discussion covers how these advanced delivery systems dramatically increase blood plasma concentration and cellular uptake of lipophilic ingredients, along with strategies to expand format versatility into powders, effervescents, and ready-to-use liquids. |
 | Hype, Hope, or Healthspan? Legitimizing Clinical Research on Bioactives for Healthy Ageing Host: Hariom Yadav, PhD, VP & Chief Scientific Officer, MUSB Research at Synbiotic Health Longevity has become the industry's most coveted claim — and its least defined. This roundtable asks what it actually takes for a supplier to build a credible scientific case that a bioactive ingredient can move the needle on healthy aging. What separates a legitimate healthspan study from marketing theater: which endpoints (aging biomarkers, biological age, validated functional and quality-of-life measures), what durations and populations, and what standard of evidence will regulators, customers, and scientists accept? Together, we will take an honest look at whether today's healthspan-positioned supplement ingredients are supported by the science, and will survive the test of time. |
 | From Hallmarks of Ageing to perceptible benefits: Rethinking Mitochondrial and NAD⁺ support and consumer-relevant outcomes Host: Gertrude Gentile-Rapinett, Director, Business Development, Dietary Supplements at dsm-firmenich Mitochondrial dysfunction, a hallmark of ageing, is closely linked to declining NAD⁺ availability, affecting electron transport, sirtuin activity and cellular energy status. At the same time, consumers may experience these changes as fatigue, slower recovery and reduced mental sharpness. This roundtable aims to explore how to connect the two and discuss how NAD⁺ precursors and cofactors can act complementarily along the same bioenergetic pathway. We will consider which functional endpoints can successfully bridge cellular mechanisms and perceived benefits, and where evidence remains limited. |
 | Beyond Longevity: Building the Healthspan Consumer Through Muscle, Bone, Joint & Skin Innovation Host: Martin Walter, Category Manager Healthy Ageing and Sports Nutrition at GELITA Healthy ageing is no longer just about living longer. Today's consumers want to stay active, strong, mobile and confident throughout life. Join this interactive roundtable discussion to explore the trends, unmet needs and innovation opportunities shaping the future of healthspan nutrition. Together, they will discuss how brands can develop differentiated solutions that address key pillars of healthy aging, including muscle mass, bone strength, joint mobility and skin health. Participants will gain practical insights into consumer expectations, product positioning strategies, and the role of clinically researched Bioactive Collagen Peptides in creating science-backed solutions for healthy ageing. |
 | Mitochondrial Health, Healthspan, and Women’s Health: A Physician’s Perspective Host: Joel Evans, M.D., OB/GYN, Director, The Center for Functional Medicine, Senior Medical Consultant to Kaneka As interest in healthy ageing continues to grow, join Dr. Joel Evans for a physician-led perspective on the role of supplements in supporting longevity, mitochondrial function, and women's health. The discussion will explore the latest science behind cellular energy production, healthy aging, hormonal changes, and targeted nutritional strategies across different life stages. Gain practical insights into evaluating supplement efficacy, safety, and quality, while addressing common misconceptions and emerging trends. This interactive conversation will provide evidence-informed perspectives on how supplementation may support overall vitality, resilience, and long-term health outcomes for women. |
 | Who Sets the Bar? Defining What Counts as Proven in Healthspan Host: Pelin Thorogood, Co-Founder & Executive Chairwoman at Radicle Science Healthspan makes one of the boldest promises in wellness: helping people live healthier for longer. But our ability to generate evidence is advancing faster than our standards for evaluating it. New research technologies are making rigorous evidence faster and more scalable; what the category still lacks is agreement on what should count as proven.Certified Effective™ is an independent third-party standard being developed in response. Pelin Thorogood, Co-founder of Radicle Science and President of Wholistic Foundation, will lead an open discussion on the evidence required, who should set the bar, and what certification must guarantee to earn trust. |
 | Cellular Energetics: NAD, Creatine and Gut Health Host: Baran Dilaver, Co-founder & CEO at Wonderfeel How does gut health influence cellular energy, resilience, and healthy ageing? This roundtable will explore the connection between intestinal barrier function, inflammation, NAD, and creatine, with a focus on what the emerging science may mean in practice. Delegates will discuss how inflammation and oxidative stress can affect the gut barrier and cellular energy over time, and explore the potential role of NAD and creatine in supporting energy and resilience. The conversation will also consider what the science tells us today, what remains to be understood, and practical opportunities for supporting long-term health. |
 | When Great Science Makes a Terrible Product: Turning Longevity Science into Products Consumers Will Actually Take Host: Lory Martin BSc (Hons) MSc, Product and Commercial Manager at Cambridge Commodities This roundtable explores the gap between compelling longevity science and the realities of creating products consumers will actually take. Bringing together expertise from science, formulation and product development, we will examine the practical challenges of translating promising longevity ingredients into effective, convenient and appealing products, from dose, format and stability to taste, compliance and consumer expectations. How do we turn exciting longevity science into products that are both scientifically credible and realistic for everyday use? |
 | From Cellular Signals to Human Outcomes: What Counts as Credible Evidence in Botanical Healthspan? Host: Andrea Zangara, Scientific Communication Advisor at Euromed During this roundtable, they’ll explore how botanical healthspan science can transition from cellular mechanisms to real-world human evidence. Using the latest research on pomegranates as a case study, we’ll explore AHR, an adaptive pathway linked to cellular defence and healthy ageing, and what a moderate increase in insulin-like growth factor 1 (IGF-1) means for older adults, particularly regarding vascular health, inflammation, and cognitive function. Join our table to examine which biomarkers are genuinely informative, how preclinical and clinical findings can be connected without overclaiming, and what evidence brands need to turn complex complex longevity science into credible product innovation. |
 | Supporting Healthy Ageing with NAD+ and NR Host: Jose Dias, M.S, Scientific & Medical Affairs Scientist at Niagen Bioscience Join an open roundtable discussion exploring the latest research on nicotinamide riboside (NR), NAD+, and healthy aging. Together, we’ll discuss what human studies reveal, how these findings relate to healthspan, and what questions remain. Attendees are encouraged to share perspectives, ask questions, and explore the potential role of NR in supporting healthy ageing. |
 | Who actually buys Longevity and Healthspan products? Host: Frank Speetjens, Managing Director of Europe at Solabia Nutrition Who is the longevity consumer? Where is demand durable and where is it a trend? Which segments are crowded and which are underserved? The category assumes it knows, and the answer keeps changing. Biohackers in their thirties, women navigating perimenopause, active retirees, GLP-1 users looking for what comes next: each behaves differently, buys differently and stays loyal for different reasons. This table opens the questions and tries to answer it together. Bring what you are seeing in your data. You will leave with a picture of who your product should be for and the white space to go for. |
 | TetraSOD® as a Cellular-Health Promoter Supporting an Active Lifestyle while Bridging Lifespan and Heathspan Host: Enrique Castaño, Sales and Business Development Director at Fitoplancton marino As interest in healthspan grows, researchers and industry are looking beyond individual aging pathways towards approaches that support cellular resilience across multiple systems. This roundtable will examine what we currently know about the interconnected roles of oxidative stress, inflammation, mitochondrial health, muscle function, immunity and the gut microbiome in healthy ageing. They’ll discuss the potential for nutritional interventions and TetraSOD to influence these processes, and discuss how scientific findings can translate into real-world outcomes. |
 | Functional Mushrooms and Healthspan: Evidence, Mechanisms, and Translational Perspectives Host: Dr. Rojison Koshy, Vice President, R&D and Operations at Ujala Life Sciences Explore the science behind functional mushrooms and their emerging role in healthspan, focusing on translating evidence into credible, scientifically grounded ingredient and formulation strategies across food, supplements, cosmetics and personal care, and pet health. They will examine bioactive compounds and biological mechanisms potentially relevant to cognitive function, cellular energy metabolism, stress response, microbiome modulation, and healthy ageing. Drawing on traditional knowledge, rapidly expanding preclinical research, and available clinical evidence, the discussion will consider what the science supports and where evidence is evolving. Delegates will gain a practical lens for evaluating evidence, identifying opportunities, and developing credible mushroom-based ingredients and products. |
 | Redefining gut health: How can fibre-bound polyphenols unlock the next generation of microbiome support? Host: Calypso Hird, Senior Marketing Specialist at Vaneeghen Emerging research is challenging how we think about fibre and gut health. This conversation will explore how the natural complexity of fruit and vegetable fibres, including fibre-bound polyphenols, can shape fermentation, microbial diversity, and postbiotic production compared with purified fibres. They’ll discuss what these findings mean for next-generation gut health solutions and how upcycled-by-design ingredients can better align with human biology, evolving consumer needs, and environmental health. |